Provided by Tiger Fintech (Singapore) Pte. Ltd.

Progenics Pharmaceuticals

4.10
+0.0000
Volume:- -
Turnover:- -
Market Cap:355.05M
PE:-5.30
High:4.10
Open:4.10
Low:4.10
Close:4.10
Loading ...
Jul 15, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 15, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 08, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 24, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jun 21, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Jun 20, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Jun 13, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Jun 06, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Jun 05, 2019

Major Issues Report

Current report, item 3.02
May 14, 2019

Major Issues Report

Current report, items 1.01 and 9.01
May 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 09, 2019

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
May 07, 2019

Major Issues Report

Current report, items 8.01 and 9.01
May 06, 2019

Major Issues Report

Current report, items 8.01 and 9.01
May 01, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Apr 30, 2019

[Rev.]Annual Report

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 14, 2019

Correspondence

[Cover]Correspondence
Oct 23, 2018

Correspondence

[Cover]Correspondence